# XVIVO Perfusion – aktieanalysens källarkiv

Company page: https://spela.port0.org/company/xvivo-perfusion
Company JSON: https://spela.port0.org/company/xvivo-perfusion/company.json
Documents JSON: https://spela.port0.org/company/xvivo-perfusion/documents.json
Updated: 2026-08-05T23:46:00Z

## Market data
- Nasdaq kurshistorik CSV: https://spela.port0.org/company/xvivo-perfusion/market/history.csv
- Nasdaq kurshistorik JSON: https://spela.port0.org/company/xvivo-perfusion/market/history.json
- Nasdaq manifest JSON: https://spela.port0.org/company/xvivo-perfusion/market/manifest.json
- Nasdaq instrumentidentitet JSON: https://spela.port0.org/company/xvivo-perfusion/market/instrument.json
- SEC sammanfattning JSON: https://spela.port0.org/company/xvivo-perfusion/market/sec-summary.json
- MFN manifest JSON: https://spela.port0.org/company/xvivo-perfusion/market/mfn-manifest.json
- Nasdaq rapportmanifest JSON: https://spela.port0.org/company/xvivo-perfusion/market/nasdaq-reports-manifest.json

## Financial reports
- Page: https://spela.port0.org/company/xvivo-perfusion/reports
- JSON: https://spela.port0.org/company/xvivo-perfusion/reports/reports.json
- 2026 Q2 | Nasdaq Nordic | Kvartalsrapport Q2 2026: https://view.news.eu.nasdaq.com/view?id=b0b5abbcfdd4cd40798dae4c97bcff593&lang=sv&src=listed
- 2026 Q1 | Nasdaq Nordic | Kvartalsrapport Q1 2026: https://view.news.eu.nasdaq.com/view?id=baa5bcbc3fc307ce23f0fdb57d979b599&lang=sv&src=listed
- 2025 Årsredovisning | Nasdaq Nordic | Årsredovisning 2025: https://view.news.eu.nasdaq.com/view?id=b7bdf0373745ab8206612b6c745615d4e&lang=sv&src=listed
- 2025 Q4 | Nasdaq Nordic | Kvartalsrapport Q4 2025: https://view.news.eu.nasdaq.com/view?id=bbf1e323680987107e9ade3e78893dd7b&lang=sv&src=listed
- 2025 Q3 | Nasdaq Nordic | Kvartalsrapport Q3 2025: https://view.news.eu.nasdaq.com/view?id=bb846263b20d9eb4e5735e73b7f34e05c&lang=sv&src=listed
- 2025 Q2 | Nasdaq Nordic | Kvartalsrapport Q2 2025: https://view.news.eu.nasdaq.com/view?id=b5e08de572f10d1b46f1f1504c3ed95ca&lang=sv&src=listed
- 2025 Q1 | Nasdaq Nordic | Kvartalsrapport Q1 2025: https://view.news.eu.nasdaq.com/view?id=bf195a344a886c58b9323b9e085ea0189&lang=sv&src=listed
- 2024 Årsredovisning | Nasdaq Nordic | Årsredovisning 2024: https://view.news.eu.nasdaq.com/view?id=b038f773b17cd4567da77aeb392d6fe21&lang=sv&src=listed
- 2024 Q4 | Nasdaq Nordic | Kvartalsrapport Q4 2024: https://view.news.eu.nasdaq.com/view?id=b4a0c118a9f163b9f0d600cee15ee0e45&lang=sv&src=listed
- 2024 Q3 | Nasdaq Nordic | Kvartalsrapport Q3 2024: https://view.news.eu.nasdaq.com/view?id=b9d7a92cabb120715b62146a39a9c4dd9&lang=sv&src=listed
- 2024 Q2 | Nasdaq Nordic | Kvartalsrapport Q2 2024: https://view.news.eu.nasdaq.com/view?id=be961082034cceda71a6bd987a87c6201&lang=sv&src=listed
- 2024 Q1 | Nasdaq Nordic | Kvartalsrapport Q1 2024: https://view.news.eu.nasdaq.com/view?id=b4f1d0d88309037de861a05447499097e&lang=sv&src=listed
- 2023 Årsredovisning | Nasdaq Nordic | Årsredovisning 2023: https://view.news.eu.nasdaq.com/view?id=b27aec971d18b8113be546f58ba6a73c3&lang=sv&src=listed
- 2023 Q4 | Nasdaq Nordic | Kvartalsrapport Q4 2023: https://view.news.eu.nasdaq.com/view?id=ba63cd9fd99559986b54b95d5b2a3b032&lang=sv&src=listed
- 2023 Q3 | Nasdaq Nordic | Kvartalsrapport Q3 2023: https://view.news.eu.nasdaq.com/view?id=b4caeb20a26fd9f1b2dfaad1117675c68&lang=sv&src=listed
- 2023 Q2 | Nasdaq Nordic | Kvartalsrapport Q2 2023: https://view.news.eu.nasdaq.com/view?id=bcc1abc698b1d0ec4edb416453c715854&lang=sv&src=listed
- 2023 Q1 | Nasdaq Nordic | Kvartalsrapport Q1 2023: https://view.news.eu.nasdaq.com/view?id=ba839d0df61e44949f3a88008d3e007b3&lang=sv&src=listed

## Morningstar Institutions
- Page: https://spela.port0.org/company/xvivo-perfusion/morningstar
- Summary: https://spela.port0.org/company/xvivo-perfusion/morningstar/summary.txt
- Screenshot: https://spela.port0.org/company/xvivo-perfusion/morningstar/screenshot.png

## Finansinspektionen
- Page: https://spela.port0.org/company/xvivo-perfusion/finansinspektionen
- Summary: https://spela.port0.org/company/xvivo-perfusion/finansinspektionen/summary.json
- Insider transactions CSV: https://spela.port0.org/company/xvivo-perfusion/finansinspektionen/insider-transactions.csv
- Insider transactions JSON: https://spela.port0.org/company/xvivo-perfusion/finansinspektionen/insider-transactions.json
- Current short positions: https://spela.port0.org/company/xvivo-perfusion/finansinspektionen/short-current.json
- Historical short positions: https://spela.port0.org/company/xvivo-perfusion/finansinspektionen/short-history.json

## Full-text source documents
- Nasdaq Nordic | Kvartalsrapport Q2 2026: https://spela.port0.org/company/xvivo-perfusion/documents/nasdaq-nordic-kvartalsrapport-q2-2026/fulltext.txt
- Nasdaq Nordic | Kvartalsrapport Q1 2026: https://spela.port0.org/company/xvivo-perfusion/documents/nasdaq-nordic-kvartalsrapport-q1-2026/fulltext.txt
- Nasdaq Nordic | Årsredovisning 2025: https://spela.port0.org/company/xvivo-perfusion/documents/nasdaq-nordic-arsredovisning-2025/fulltext.txt
  - HTML part 1: https://spela.port0.org/company/xvivo-perfusion/documents/nasdaq-nordic-arsredovisning-2025/part-001.html
  - HTML part 2: https://spela.port0.org/company/xvivo-perfusion/documents/nasdaq-nordic-arsredovisning-2025/part-002.html
- Nasdaq Nordic | Kvartalsrapport Q4 2025: https://spela.port0.org/company/xvivo-perfusion/documents/nasdaq-nordic-kvartalsrapport-q4-2025/fulltext.txt
- Nasdaq Nordic | Kvartalsrapport Q3 2025: https://spela.port0.org/company/xvivo-perfusion/documents/nasdaq-nordic-kvartalsrapport-q3-2025/fulltext.txt
- Nasdaq Nordic | Kvartalsrapport Q2 2025: https://spela.port0.org/company/xvivo-perfusion/documents/nasdaq-nordic-kvartalsrapport-q2-2025/fulltext.txt
- Nasdaq Nordic | Kvartalsrapport Q1 2025: https://spela.port0.org/company/xvivo-perfusion/documents/nasdaq-nordic-kvartalsrapport-q1-2025/fulltext.txt
- Nasdaq Nordic | Årsredovisning 2024: https://spela.port0.org/company/xvivo-perfusion/documents/nasdaq-nordic-arsredovisning-2024/fulltext.txt
  - HTML part 1: https://spela.port0.org/company/xvivo-perfusion/documents/nasdaq-nordic-arsredovisning-2024/part-001.html
  - HTML part 2: https://spela.port0.org/company/xvivo-perfusion/documents/nasdaq-nordic-arsredovisning-2024/part-002.html
- Nasdaq Nordic | Kvartalsrapport Q4 2024: https://spela.port0.org/company/xvivo-perfusion/documents/nasdaq-nordic-kvartalsrapport-q4-2024/fulltext.txt
- Nasdaq Nordic | Kvartalsrapport Q3 2024: https://spela.port0.org/company/xvivo-perfusion/documents/nasdaq-nordic-kvartalsrapport-q3-2024/fulltext.txt
- Nasdaq Nordic | Kvartalsrapport Q2 2024: https://spela.port0.org/company/xvivo-perfusion/documents/nasdaq-nordic-kvartalsrapport-q2-2024/fulltext.txt
- Nasdaq Nordic | Kvartalsrapport Q1 2024: https://spela.port0.org/company/xvivo-perfusion/documents/nasdaq-nordic-kvartalsrapport-q1-2024/fulltext.txt
- Nasdaq Nordic | Årsredovisning 2023: https://spela.port0.org/company/xvivo-perfusion/documents/nasdaq-nordic-arsredovisning-2023/fulltext.txt
  - HTML part 1: https://spela.port0.org/company/xvivo-perfusion/documents/nasdaq-nordic-arsredovisning-2023/part-001.html
  - HTML part 2: https://spela.port0.org/company/xvivo-perfusion/documents/nasdaq-nordic-arsredovisning-2023/part-002.html
- Nasdaq Nordic | Kvartalsrapport Q4 2023: https://spela.port0.org/company/xvivo-perfusion/documents/nasdaq-nordic-kvartalsrapport-q4-2023/fulltext.txt
- Nasdaq Nordic | Kvartalsrapport Q3 2023: https://spela.port0.org/company/xvivo-perfusion/documents/nasdaq-nordic-kvartalsrapport-q3-2023/fulltext.txt
- Nasdaq Nordic | Kvartalsrapport Q2 2023: https://spela.port0.org/company/xvivo-perfusion/documents/nasdaq-nordic-kvartalsrapport-q2-2023/fulltext.txt
- Nasdaq Nordic | Kvartalsrapport Q1 2023: https://spela.port0.org/company/xvivo-perfusion/documents/nasdaq-nordic-kvartalsrapport-q1-2023/fulltext.txt
- MFN | MFN bolagssida och bolagsmetadata: https://spela.port0.org/company/xvivo-perfusion/documents/mfn-mfn-bolagssida-och-bolagsmetadata/fulltext.txt